![Thomas Mark Cavell-Taylor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Mark Cavell-Taylor
Directeur/Bestuurslid bij CPI Innovation Services Ltd.
Profiel
Thomas Mark Cavell-Taylor is currently a Director at CPI Innovation Services Ltd.
He was previously an Executive Director at Nuformix Technologies Ltd.
Actieve functies van Thomas Mark Cavell-Taylor
Bedrijven | Functie | Begin |
---|---|---|
CPI Innovation Services Ltd.
![]() CPI Innovation Services Ltd. Information Technology ServicesTechnology Services Founded in 2006, CPI Innovation Services Ltd. is a subsidiary of Centre for Process Innovation Ltd. The company is based in Redcar, UK. The British company provides technology services and conducts research and development in testing and pilot scale production facilities. | Directeur/Bestuurslid | 14-04-2010 |
Eerdere bekende functies van Thomas Mark Cavell-Taylor
Bedrijven | Functie | Einde |
---|---|---|
Nuformix Technologies Ltd.
![]() Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Nuformix Technologies Ltd.
![]() Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
CPI Innovation Services Ltd.
![]() CPI Innovation Services Ltd. Information Technology ServicesTechnology Services Founded in 2006, CPI Innovation Services Ltd. is a subsidiary of Centre for Process Innovation Ltd. The company is based in Redcar, UK. The British company provides technology services and conducts research and development in testing and pilot scale production facilities. | Technology Services |